SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-060058
Filing Date
2018-11-27
Accepted
2018-11-27 19:10:56
Documents
1
Period of Report
2018-11-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1577
  Complete submission text file 0001209191-18-060058.txt   3007
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6035 STONERIDGE DRIVE PLEASANTON CA 94588
Business Address
Smith David V (Reporting) CIK: 0001229447 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36070 | Film No.: 181203938